Global Cancer Immunotherapy Market Size & Outlook, 2026-2033
Global cancer immunotherapy market, 2021-2033 (US$M)
Related Markets
Global cancer immunotherapy market highlights
- The global cancer immunotherapy market generated a revenue of USD 153,268.5 million in 2025 and is expected to reach USD 305,803.0 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 9.1% by 2033.
- In terms of segment, monoclonal antibodies accounted for a revenue of USD 100,372.2 million in 2025.
- Oncolytic Viral Therapies and Cancer Vaccines is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 153,268.5 million |
| Market revenue in 2033 | USD 305,803.0 million |
| Growth rate | 9.1% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Oncolytic Viral Therapies and Cancer Vaccines |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies, Check Point Inhibitors, Oncolytic Viral Therapies and Cancer Vaccines |
Other key industry trends
- In terms of revenue, the North America accounted for 43.3% of the global cancer immunotherapy market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 6,761.3 million by 2033.
Monoclonal antibodies was the largest segment with a revenue share of 65.49% in 2025. Horizon Databook has segmented the Global cancer immunotherapy market based on monoclonal antibodies, check point inhibitors, oncolytic viral therapies and cancer vaccines covering the revenue growth of each sub-segment from 2021 to 2033.
Rise in prevalence of multiple cancers and the increase in need to provide efficient methods to detect them at early stages to enable timely appropriate treatment are anticipated to drive the market. For instance, according to the International Agency for Research on Cancer (IARC), over 20.7 million new cancer cases are expected in 2023.
Globally, cancer is a leading cause of death, accounting for 10 million deaths in 2020, or one in every six individuals. One-third of cancer-related deaths are attributed to factors such as smoking, high body mass index, alcohol abuse, obesity, and high cholesterol. Awareness among people about early diagnosis available treatment options and advancements in treatments have substantially improved patient outcomes.
According to OECD in 2020, about 2.7 million people in the EU were expected to be diagnosed with some form of cancer. Ireland, Belgium, Denmark, and the Netherlands are expected to show a higher incidence of cancer. Cancer is the second leading cause of mortality in Europe, after cardiovascular diseases. An estimated 1.3 million people died of cancer in 2020.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Immunotherapy Market Scope
Cancer Immunotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Immunocore Holdings PLC ADR | View profile | 497 | 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RY | https://www.immunocore.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Global cancer immunotherapy market size, by regions, 2021-2033 (US$M)
Top 10 countries: Cancer immunotherapy market size, 2025 (US$M)
Global cancer immunotherapy market share, by product, 2025 & 2033 (%, US$M)
Cancer immunotherapy market: Opportunity assessment by country
Global cancer immunotherapy market, by region, 2025 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
